SIOUX FALLS, S.D. (KELO.com) — SAb Biotherapeutics in northern Sioux Falls is using its breakthrough technology — and a herd of cows — to quickly develop an effective treatment for the COVID-19 disease, which is spreading across the world and the U.S., infecting thousands. The company uses genetically engineered cows to produce human antibodies that fight specific diseases.
SAb has emerged as a major player in the effort to isolate and generate a viable antidote to the fast-moving virus that is sweeping across the world and the United States, so far sickening more than 140,000 and killing several thousand.
Eddie Sullivan, CEO of SAb, said the company is working on producing a polyclonal antibody therapeutic to coronavirus that it expects will be ready for the pre-clinical and clinical-trial evaluations by the end of the summer, paving the way for a potential treatment shortly thereafter, depending on the pace of regulatory approval.
In the latest piece published by South Dakota News Watch, available here, Content Director Bart Pfankuch explains what the company is trying to do and how its work could help those sickened by the coronavirus.
